News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,330 Results
Type
Article (67348)
Company Profile (799)
Press Release (750157)
Multimedia
Podcasts (172)
Webinars (25)
Section
Business (223887)
Career Advice (2972)
Deals (38409)
Drug Delivery (151)
Drug Development (87953)
Employer Resources (184)
FDA (17882)
Job Trends (16868)
News (379798)
Policy (36980)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2986)
Academic (1)
Accelerated approval (44)
Adcomms (31)
Allergies (174)
Alliances (54563)
ALS (204)
Alzheimer's disease (1861)
Antibody-drug conjugate (ADC) (405)
Approvals (18136)
Artificial intelligence (667)
Autoimmune disease (242)
Automation (52)
Bankruptcy (388)
Best Places to Work (12594)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (473)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (720)
Cancer (5587)
Cardiovascular disease (492)
Career advice (2515)
Career pathing (43)
CAR-T (324)
CDC (70)
Celiac Disease (2)
Cell therapy (871)
Cervical cancer (43)
Clinical research (75140)
Collaboration (2060)
Company closure (5)
Compensation (1312)
Complete response letters (88)
COVID-19 (2959)
CRISPR (109)
C-suite (1049)
Cystic fibrosis (158)
Data (7244)
Decentralized trials (3)
Denatured (45)
Depression (173)
Dermatology (57)
Diabetes (578)
Diagnostics (7347)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (321)
Drug pricing (228)
Drug shortages (34)
Duchenne muscular dystrophy (279)
Earnings (97269)
Editorial (71)
Employer branding (22)
Employer resources (162)
Events (131725)
Executive appointments (1111)
FDA (21437)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1719)
Gene editing (231)
Generative AI (62)
Gene therapy (722)
GLP-1 (1167)
Government (5276)
Grass and pollen (8)
Guidances (400)
Healthcare (20839)
HIV (78)
Huntington's disease (58)
IgA nephropathy (95)
Immunology and inflammation (314)
Immuno-oncology (90)
Indications (158)
Infectious disease (3299)
Inflammatory bowel disease (220)
Inflation Reduction Act (16)
Influenza (138)
Intellectual property (283)
Interviews (516)
IPO (17615)
IRA (60)
Job creations (4664)
Job search strategy (2107)
JPM (73)
Kidney cancer (19)
Labor market (94)
Layoffs (638)
Leadership (43)
Legal (9136)
Liver cancer (106)
Longevity (29)
Lung cancer (743)
Lymphoma (415)
Machine learning (54)
Management (65)
Manufacturing (991)
MASH (190)
Medical device (14988)
Medtech (15071)
Mergers & acquisitions (21977)
Metabolic disorders (1549)
mRNA (203)
Multiple sclerosis (178)
NASH (23)
Neurodegenerative disease (422)
Neuropsychiatric disorders (111)
Neuroscience (3359)
Neurotech (1)
NextGen: Class of 2026 (7549)
Non-profit (5107)
Now hiring (74)
Obesity (751)
Opinion (344)
Ovarian cancer (189)
Pain (248)
Pancreatic cancer (267)
Parkinson's disease (363)
Partnered (35)
Patents (577)
Patient recruitment (620)
Peanut (65)
People (65167)
Pharmaceutical (134)
Pharmacy benefit managers (36)
Phase 1 (23325)
Phase 2 (32776)
Phase 3 (24690)
Pipeline (7309)
Policy (358)
Postmarket research (3083)
Preclinical (10199)
Press Release (72)
Prostate cancer (288)
Psychedelics (57)
Radiopharmaceuticals (329)
Rare diseases (1089)
Real estate (7046)
Recruiting (74)
Regulatory (27841)
Reports (55)
Research institute (2720)
Resumes & cover letters (475)
Rett syndrome (33)
RNA editing (19)
RSV (92)
Schizophrenia (177)
Series A (287)
Series B (213)
Service/supplier (29)
Sickle cell disease (114)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (46)
Startups (4103)
State (2)
Stomach cancer (20)
Supply chain (126)
Tariffs (101)
The Weekly (124)
Vaccines (1180)
Venture capital (108)
Weight loss (509)
Women's health (111)
Worklife (21)
Date
Last 7 days (670)
Last 30 days (2590)
Last 365 days (31912)
2026 (8511)
2025 (32260)
2024 (37646)
2023 (42393)
2022 (53780)
2021 (58581)
2020 (57529)
2019 (51029)
2018 (38726)
2017 (35426)
2016 (35606)
2015 (41757)
2014 (36899)
2013 (33876)
2012 (33981)
2011 (34479)
2010 (33387)
Location
Africa (1016)
Alabama (98)
Alaska (7)
Arizona (361)
Arkansas (15)
Asia (47364)
Australia (8165)
California (12743)
Canada (3589)
China (1326)
Colorado (545)
Connecticut (557)
Delaware (383)
Europe (107278)
Florida (1904)
Georgia (417)
Hawaii (4)
Idaho (67)
Illinois (1046)
India (87)
Indiana (595)
Iowa (24)
Japan (504)
Kansas (137)
Kentucky (50)
Louisiana (44)
Maine (85)
Maryland (1573)
Massachusetts (9330)
Michigan (378)
Minnesota (720)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (30)
Nevada (142)
New Hampshire (89)
New Jersey (3440)
New Mexico (31)
New York (3379)
North Carolina (1737)
North Dakota (10)
Northern California (6223)
Ohio (393)
Oklahoma (25)
Oregon (54)
Pennsylvania (2552)
Puerto Rico (27)
Rhode Island (53)
South America (1396)
South Carolina (78)
South Dakota (1)
Southern California (4987)
Tennessee (206)
Texas (2034)
United States (45814)
Utah (383)
Vermont (1)
Virginia (326)
Washington D.C. (87)
Washington State (1055)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
818,330 Results for "new river pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
February 18, 2026
·
20 min read
Job Trends
11 Companies Hiring Now in New York
Looking for a biopharma job in New York? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
March 25, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
February 24, 2026
·
6 min read
Press Releases
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
February 25, 2026
·
3 min read
Press Releases
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
January 22, 2026
·
1 min read
Press Releases
Charles River Laboratories to Present at Evercore Healthcare Conference
December 2, 2025
·
1 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Press Releases
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
January 8, 2026
·
11 min read
Press Releases
Charles River Laboratories to Present at Jefferies Global Healthcare Conference 2025
November 18, 2025
·
1 min read
Press Releases
Charles River Laboratories Provides Update on Strategic Review
November 5, 2025
·
9 min read
Previous
2 of 81,833
Next
